Ratings by BTIG (Justin Zelin)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/22/2026 | Immunitybio Inc | IBRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2025 | ArriVent BioPharma | AVBP | New Coverage | Buy (N/A) |
24.91 (23.43) |
-5.94% | Details | |
| 12/9/2025 | Tscan Therapeutics Inc | TCRX | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/13/2025 | Mersana | MRSN | Downgrade | Neutral (Buy) |
8.87 (29.08) |
227.85% | Details | |
| 11/13/2025 | Lyra Therapeutics | LYRA | Maintain | Neutral (Neutral) |
|
Details | ||
| 11/10/2025 | Ascentage Pharma Group | AAPG | New Coverage | Buy (N/A) |
31.73 (23.14) |
-27.07% | Details | |
| 11/4/2025 | Tscan Therapeutics Inc | TCRX | Downgrade | Neutral (Buy) |
1.24 (1.12) |
-9.68% | Details | |
| 10/23/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2025 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2025 | I-Mab | IMAB | New Coverage | Buy (N/A) |
4.27 (4.63) |
8.43% | Details | |
| 8/19/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Enliven Therapeutics | ELVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Verastem | VSTM | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | Mersana | MRSN | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2025 | Innate Pharma S.A. | IPHA | New Coverage | Buy (N/A) |
2.03 (1.60) |
-21.18% | Details | |
| 7/7/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2025 | Verastem | VSTM | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | Lyra Therapeutics | LYRA | Maintain | Neutral (N/A) |
|
Details | ||
| 5/16/2025 | Enliven Therapeutics | ELVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2025 | Immunitybio Inc | IBRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2025 | BioAtla Inc. | BCAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2025 | Verastem | VSTM | Maintain | Buy (Buy) |
|
Details | ||
| 3/11/2025 | Immunocore Holdings | IMCR | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2025 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2025 | Kura Oncology | KURA | Downgrade | Neutral (Buy) |
9.05 (8.96) |
-0.99% | Details | |
| 1/21/2025 | Ideaya Biosciences | IDYA | Maintain | Buy (Buy) |
|
Details | ||
| 1/16/2025 | Verastem | VSTM | Maintain | Buy (Buy) |
|
Details | ||
| 1/10/2025 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2025 | Immunitybio Inc | IBRX | New Coverage | Buy (N/A) |
2.56 (8.67) |
238.67% | Details | |
| 1/8/2025 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2024 | Verastem | VSTM | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2024 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2024 | Enliven Therapeutics | ELVN | New Coverage | Buy (N/A) |
23.00 (29.44) |
28% | Details | |
| 12/10/2024 | Carisma Therapeutics Inc | CARM | Downgrade | Neutral (Buy) |
0.80 (0.15) |
-81.25% | Details | |
| 12/3/2024 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2024 | Viking Therapeutic | VKTX | Maintain | Buy (Buy) |
|
Details | ||
| 11/26/2024 | Poseida Therapeutics, Inc | PSTX | Downgrade | Neutral (Buy) |
2.86 (9.50) |
232.17% | Details | |
| 10/24/2024 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2024 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2024 | Jasper Therapeutics | JSPR | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2024 | Poseida Therapeutics, Inc | PSTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2024 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | ProKidney Corp. | PROK | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2024 | BioAtla Inc. | BCAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | ProKidney Corp. | PROK | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Mersana | MRSN | New Coverage | Buy (N/A) |
1.45 (8.87) |
511.72% | Details | |
| 8/13/2024 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
35.86 (13.84) |
-61.41% | Details | |
| 8/13/2024 | BioAtla Inc. | BCAB | New Coverage | Buy (N/A) |
1.47 (0.17) |
-88.44% | Details | |
| 7/17/2024 | Legend Biotech Corp. | LEGN | Maintain | Buy (Buy) |
|
Details | ||
| 7/8/2024 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2024 | Jasper Therapeutics | JSPR | New Coverage | Buy (N/A) |
21.14 (1.38) |
-93.47% | Details | |
| 7/8/2024 | Jasper Therapeutics | JSPR | New Coverage | Buy (N/A) |
21.14 (1.38) |
-93.47% | Details | |
| 7/5/2024 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2024 | Viking Holdings | VIK | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2024 | ProKidney Corp. | PROK | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2024 | Verastem | VSTM | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Tscan Therapeutics Inc | TCRX | New Coverage | Buy (N/A) |
8.93 (1.24) |
-86.11% | Details | |
| 5/6/2024 | Lyra Therapeutics | LYRA | Downgrade | Neutral (Buy) |
4.03 (1.28) |
-68.24% | Details | |
| 4/11/2024 | Carisma Therapeutics Inc | CARM | New Coverage | Buy (N/A) |
1.91 (0.80) |
-58.12% | Details | |
| 3/26/2024 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | Ideaya Biosciences | IDYA | New Coverage | Buy (N/A) |
46.36 (33.19) |
-28.41% | Details | |
| 12/26/2023 | Gracell Biotechnologies Inc | GRCL | Downgrade | Neutral (Buy) |
6.19 (10.25) |
65.59% | Details | |
| 11/21/2023 | Verastem | VSTM | New Coverage | Buy (N/A) |
6.45 (6.38) |
-1.09% | Details | |
| 11/15/2023 | ProKidney Corp. | PROK | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2023 | Mustang Bio | MBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2023 | Lyra Therapeutics | LYRA | New Coverage | Buy (N/A) |
3.85 (4.03) |
4.68% | Details | |
| 8/15/2023 | Mustang Bio | MBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Immunocore Holdings | IMCR | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Aravive Inc. | ARAV | Downgrade | Neutral (Buy) |
1.31 (0.04) |
-96.95% | Details | |
| 7/24/2023 | ProKidney Corp. | PROK | New Coverage | Buy (N/A) |
11.60 (2.30) |
-80.17% | Details | |
| 7/21/2023 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2023 | Aravive Inc. | ARAV | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2023 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2023 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2023 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/13/2023 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/13/2023 | Gracell Biotechnologies Inc | GRCL | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2023 | Kura Oncology | KURA | New Coverage | Buy (N/A) |
12.66 (9.05) |
-28.52% | Details | |
| 5/16/2023 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2023 | BELLUS Health Inc. | BLU | Downgrade | Neutral (Buy) |
7.26 (14.74) |
103.03% | Details | |
| 4/17/2023 | Syndax Pharmaceuticals | SNDX | New Coverage | Buy (N/A) |
20.20 (22.07) |
9.26% | Details | |
| 4/17/2023 | Aravive Inc. | ARAV | New Coverage | Buy (N/A) |
1.73 (0.04) |
-97.69% | Details | |
| 3/22/2023 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2022 | MEI Pharma | MEIP | Downgrade | Neutral (Buy) |
0.41 (3.07) |
648.78% | Details | |
| 11/16/2022 | CASI Pharmaceuticals | CASI | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | Mustang Bio | MBIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Poseida Therapeutics, Inc | PSTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2022 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2022 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2022 | CASI Pharmaceuticals | CASI | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2022 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2022 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2022 | Mustang Bio | MBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2022 | Surface Oncology | SURF | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Enact Holdings Inc | ACT | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2022 | Gracell Biotechnologies Inc | GRCL | New Coverage | Buy (N/A) |
2.24 (10.25) |
357.59% | Details | |
| 3/25/2022 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Legand Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2021 | BELLUS Health Inc. | BLU | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2021 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2021 | Enact Holdings Inc | ACT | New Coverage | Buy (N/A) |
20.91 (41.44) |
98.18% | Details | |
| 10/7/2021 | Legand Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2021 | Surface Oncology | SURF | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2021 | Viking Therapeutic | VKTX | New Coverage | Buy (N/A) |
5.86 (32.98) |
462.8% | Details | |
| 7/29/2021 | 89bio Inc. | ETNB | New Coverage | Buy (N/A) |
14.91 (14.84) |
-0.47% | Details | |
| 6/14/2021 | Mustang Bio | MBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2021 | Surface Oncology | SURF | New Coverage | Buy (N/A) |
7.87 (1.07) |
-86.4% | Details | |
| 5/18/2021 | Poseida Therapeutics, Inc | PSTX | New Coverage | Buy (N/A) |
8.40 (9.50) |
13.1% | Details | |
| 5/18/2021 | Mustang Bio | MBIO | New Coverage | Buy (N/A) |
2.79 (0.90) |
-67.74% | Details | |
| 5/18/2021 | Legand Biotech Corp. | LEGN | New Coverage | Buy (N/A) |
29.60 (18.97) |
-35.91% | Details | |
| 5/18/2021 | Adicet Bio Inc. | ACET | New Coverage | Buy (N/A) |
27.04 (7.29) |
-73.04% | Details | |
| 5/18/2021 | CASI Pharmaceuticals | CASI | New Coverage | Buy (N/A) |
1.45 (0.21) |
-85.52% | Details |
